Papain-like peptidases: Structure, function, and evolution

Biomolecular Concepts

Volumn 4, Issue 3, 2013, Pages 287-308

  Novinec, Marko ^a   Lenarcic, Brigita ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cysteine cathepsins; Lysosomal enzymes; Proteolysis

Indexed keywords

PAPAIN; PEPTIDE HYDROLASE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; ENZYME ACTIVE SITE; HUMAN; MOLECULAR EVOLUTION; PHYLOGENY; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE;

ANIMALS; CATALYTIC DOMAIN; EVOLUTION, MOLECULAR; HUMANS; MODELS, MOLECULAR; PAPAIN; PEPTIDE HYDROLASES; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY;

EID: 84881602259     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2012-0054     Document Type: Review

References (201)

1. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 2012; 40: D343-50.
2. M é nard R, Carri è re J, Laflamme P, Plouffe C, Khouri HE, Vernet T, Tessier DC, Thomas DY, Storer AC. Contribution of the glutamine 19 side chain to transition-state stabilization in the oxyanion hole of papain. Biochemistry 1991; 30: 8924-8.
3. Vernet T, Tessier DC, Chatellier J, Plouffe C, Lee TS, Thomas DY, Storer AC, Menard R. Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem 1995; 270: 16645-52.
4. Gul S, Hussain S, Thomas MP, Resmini M, Verma CS, Thomas EW, Brocklehurst K. Generation of nucleophilic character in the Cys25/His159 ion pair of papain involves Trp177 but not Asp158. Biochemistry 2008; 47: 2025-35.
5. Novinec M, KovaiL, LenariB, Baici A. Conformational flexibility and allosteric regulation of cathepsin K. Biochem J 2010; 429: 379-89.
6. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967; 27: 157-62.
7. Turk D, Gunar G, Podobnik M, Turk B. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem 1998; 379: 137-47.
8. Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, PopoviT, Turk V, Towatari T, Katunuma N, Bode W. The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J 1991; 10: 2321-30.
9. Gunar G, KlemeniI, Turk B, Turk V, Karaoglanovi-Carmona A, Juliano L, Turk D. Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxydipeptidase activity of the protease. Structure 2000; 8: 305-13.
10. Gunar G, Podobnik M, Pungerar J, ŝ trukelj B, Turk V, Turk D. Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 1998; 6: 51-61.
11. Turk D, Janji V, Stern I, Podobnik M, Lamba D, Dahl SW, Lauritzen C, Pedersen J, Turk V, Turk B. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J 2001; 20: 6570-82.
12. McDonald JK, Reilly TJ, Zeitman BB, Ellis S. Cathepsin C: a chloride-requiring enzyme. Biochem Biophys Res Commun 1966; 24: 771-5.
13. Nogaroto V, Tagliavini S, Gianotti A, Mikawa A, Barros NT, Puzer L, Carmona AK, Costa P, Henrique-Silva F. Recombinant expression and characterization of a Xylella fastidiosa cysteine protease differentially expressed in a nonpathogenic strain. FEMS Microbiol Lett 2006; 261: 187-93.
14. Karrer KM, Peiffer SL, DiTomas ME. Two distinct gene subfamilies within the family of cysteine protease genes. Proc Natl Acad Sci USA 1993; 90: 3063-7.
15. Wex T, Levy B, Wex H, Brömme D. Human cathepsins F and W: a new subgroup of cathepsins. Biochem Biophys Res Commun 1999; 259: 401-7.
16. Ward W, Alvarado L, Rawlings ND, Engel JC, Franklin C, McKerrow JH. A primitive enzyme for a primitive cell: the protease required for excystation of Giardia. Cell 1997; 89: 437-44.
17. Richau KH, Kaschani F, Verdoes M, Pansuriya TC, Niessen S, Stüber K, Colby T, Overkleeft HS, Bogyo M, Van der Hoorn RA. Subclassification and biochemical analysis of plant papain-like cysteine proteases displays subfamily-specific characteristics. Plant Physiol 2012; 158: 1583-99.
18. Fujimoto Y, Kobayashi A, Kurata S, Natori S. Two subunits of the insect 26/29-kDa proteinase are probably derived from a common precursor protein. J Biochem 1999; 125: 566-73.
19. Rogers JC, Dean D, Heck GR. Aleurain: a barley thiol protease closely related to mammalian cathepsin H. Proc Natl Acad Sci USA 1985; 82: 6512-6.
20. Reif MM, Mach L, Oostenbrink C. Molecular insight into propeptide-protein interactions in cathepsins L and O. Biochemistry 2012; 51: 8636-53.
21. Stoch SA, Wagner JA. Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin Pharmacol Ther 2008; 83: 172-6.
22. Brix K, Dunkhorst A, Mayer K, Jordans S. Cysteine cathepsins: cellular roadmap to different functions. Biochimie 2008; 90: 194-207.
23. Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006; 6: 764-75.
24. Cheng XW, Huang Z, Kuzuya M, Okumura K, Murohara T. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension 2011; 58: 978-86.
25. Veillard F, Lecaille F, Lalmanach G. Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system? Int J Biochem Cell Biol 2008; 40: 1079-94.
26. Conus S, Simon HU. Cathepsins and their involvement in immune responses. Swiss Med Wkly 2010; 140: w13042.
27. Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G. Cysteine cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces β-amyloid of Alzheimer's disease. Biochim Biophys Acta 2012; 1824: 89-104.
28. Bond JS, Barrett AJ. Degradation of fructose-1,6-bisphosphate aldolase by cathepsin B. Biochem J 1980; 189: 17-25.
29. Takahashi T, Dehdarani AH, Yonezawa S, Tang J. Porcine spleen cathepsin B is an exopeptidase. J Biol Chem 1986; 261: 9375-81.
30. Dean RT, Barrett AJ. Lysosomes. Essays Biochem 1976; 12: 1-40.
31. Matsunaga Y, Saibara T, Kido H, Katunuma N. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett 1993; 324: 325-30.
32. Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, Brix K. Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 2003; 111: 1733-45.
33. Okamura-Oho Y, Zhang S, Callahan JW, Murata M, Oshima A, Suzuki Y. Maturation and degradation of β-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease. FEBS Lett 1997; 419: 231-4.
34. Michallet MC, Saltel F, Preville X, Flacher M, Revillard JP, Genestier L. Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood 2003; 102: 3719-26.
35. LenariB, Gabrijelcic D, Rozman B, Drobni-Koŝorok M, Turk V. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe-Seyler 1988; 369 Suppl: 257-61.
36. Baici A, Lang A, Horler D, Kissling R, Merlin C. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis 1995; 54: 289-97.
37. Baici A, Horler D, Lang A, Merlin C, Kissling R. Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage. Ann Rheum Dis 1995; 54: 281-8.
38. Cavallo-Medved D, Mai J, Dosescu J, Sameni M, Sloane BF. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. J Cell Sci 2005; 118: 1493-503.
39. Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res 2009; 315: 1234-46.
40. Tu C, Ortega-Cava CF, Chen G, Fernandes ND, Cavallo-Medved D, Sloane BF, Band V, Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. Cancer Res 2008; 68: 9147-56.
41. Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D. Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem 1999; 264: 100-9.
42. Khouri HE, Plouffe C, Hasnain S, Hirama T, Storer AC, Menard R. A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses. Biochem J 1991; 275 Pt 3: 751-7.
43. Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF. Degradation of laminin by human tumor cathepsin B. Clin. Exp. Metastasis 1989; 7: 461-8.
44. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 1992; 282 Pt 1: 273-8.
45. Mai J, Sameni M, Mikkelsen T, Sloane BF. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biol Chem 2002; 383: 1407-13.
46. Premzl A, Zavaŝnik-Bergant V, Turk V, Kos J. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 2003; 283: 206-14.
47. Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveu J, Lane W, Hook G, Reisine T. Inhibition of cathepsin B reduces β-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate β-secretase of Alzheimer ' s disease. Biol Chem 2005; 386: 931-40.
48. Hook VY, Kindy M, Reinheckel T, Peters C, Hook G. Genetic cathepsin B deficiency reduces β-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun 2009; 386: 284-8.
49. Wang C, Sun B, Zhou Y, Grubb A, Gan L. Cathepsin B degrades amyloid-β in mice expressing wildtype human amyloid precursor protein. J Biol Chem 2012; 287: 39834-41.
50. Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, Devidze N, Wang X, Grubb A, Gan L. Cystatin C-cathepsin B axis regulates amyloid β levels and associated neuronal deficits in an animal model of Alzheimer ' s disease. Neuron 2008; 60: 247-57.
51. Gilroy EM, Hein I, van der Hoorn R, Boevink PC, Venter E, McLellan H, Kaffarnik F, Hrubikova K, Shaw J, Holeva M, López EC, Borras-Hidalgo O, Pritchard L, Loake GJ, Lacomme C, Birch PR. Involvement of cathepsin B in the plant disease resistance hypersensitive response. Plant J 2007; 52: 1-13.
52. McLellan H, Gilroy EM, Yun BW, Birch PR, Loake GJ. Functional redundancy in the Arabidopsis Cathepsin B gene family contributes to basal defence, the hypersensitive response and senescence. New Phytol 2009; 183: 408-18.
53. El-Fadili AK, Zangger H, Desponds C, Gonzalez IJ, Zalila H, Schaff C, Ives A, Masina S, Mottram JC, Fasel N. Cathepsin B-like and cell death in the unicellular human pathogen Leishmania. Cell Death Dis 2010; 1: e71.
54. Somanna A, Mundodi V, Gedamu L. Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor β . J Biol Chem 2002; 277: 25305-12.
55. Que X, Ngo H, Lawton J, Gray M, Liu Q, Engel J, Brinen L, Ghosh P, Joiner KA, Reed SL. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J Biol Chem 2002; 277: 25791-7.
56. DuBois KN, Abodeely M, Sakanari J, Craik CS, Lee M, McKerrow JH, Sajid M. Identification of the major cysteine protease of Giardia and its role in encystation. J Biol Chem 2008; 283: 18024-31.
57. Cancela M, Acosta D, Rinaldi G, Silva E, Durán R, Roche L, Zaha A, Carmona C, Tort JF. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica. Biochimie 2008; 90: 1461-75.
58. Klemeni, I, Carmona AK, Cezari MH, Juliano MA, Juliano L, Gunar G, Turk D, Kriẑaj I, Turk V, Turk B. Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase. Eur J Biochem 2000; 267: 5404-12.
59. Therrien C, Lachance P, Sulea T, Purisima EO, Qi H, Ziomek E, Alvarez-Hernandez A, Roush WR, M é nard R. Cathepsins X and B can be differentiated through their respective mono-and dipeptidyl carboxypeptidase activities. Biochemistry 2001; 40: 2702-11.
60. Puzer L, Cotrin SS, Cezari MH, Hirata IY, Juliano MA, Stefe I, Turk D, Turk B, Juliano L, Carmona AK. Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L. Biol Chem 2005; 386: 1191-5.
61. Obermajer N, ŝvajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. J Leukoc Biol 2008; 84: 1306-15.
62. Obermajer N, Repnik U, Jevnikar Z, Turk B, Kreft M, Kos J. Cysteine protease cathepsin X modulates immune response via activation of β 2 integrins. Immunology 2008; 124: 76-88.
63. Lechner AM, Assfalg-Machleidt I, Zahler S, Stoeckelhuber M, Machleidt W, Jochum M, N ä gler DK. RGD-dependent binding of procathepsin X to integrin α v β 3 mediates cell-adhesive properties. J Biol Chem 2006; 281: 39588-97.
64. Nascimento FD, Rizzi CC, Nantes IL, ŝtefe I, Turk B, Carmona AK, Nader HB, Juliano L, Tersariol IL. Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch Biochem Biophys 2005; 436: 323-32.
65. Wendt W, Zhu XR, Lubbert H, Stichel CC. Differential expression of cathepsin X in aging and pathological central nervous system of mice. Exp Neurol 2007; 204: 525-40.
66. Obermajer N, Doljak B, Jamnik P, Fonovi UP, Kos J. Cathepsin X cleaves the C-terminal dipeptide of α-and -enolase and impairs survival and neuritogenesis of neuronal cells. Int J Biochem Cell Biol 2009; 41: 1685-96.
67. N ä gler DK, Kraus S, Feierler J, Mentele R, Lottspeich F, Jochum M, Faussner A. A cysteine-type carboxypeptidase, cathepsin X, generates peptide receptor agonists. Int Immunopharmacol 2010; 10: 134-9.
68. Jevnikar Z, Obermajer N, Kos J. LFA-1 fine-tuning by cathepsin X. IUBMB Life 2011; 63: 686-93.
69. Staudt ND, Aicher WK, Kalbacher H, Stevanovic S, Carmona AK, Bogyo M, Klein G. Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematologica 2010; 95: 1452-60.
70. Krueger S, Kalinski T, Hundertmark T, Wex T, K üster D, Peitz U, Ebert M, N ä gler DK, Kellner U, Malfertheiner P, Naumann M, Röcken C, Roessner A. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 2005; 207: 32-42.
71. CigiB, Dahl SW, Pain RH. The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme. Biochemistry 2000; 39: 12382-90.
72. Horn M, Baudys M, Voburka Z, Kluh I, Vondrasek J, Mares M. Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I). Protein Sci 2002; 11: 933-43.
73. Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, Zhang Y, Firatli E. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J Med Genet 1999; 36: 881-7.
74. McGuire MJ, Lipsky PE, Thiele DL. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem 1993; 268: 2458-67.
75. Pham CT, Ley TJ. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999; 96: 8627-32.
76. Sheth PD, Pedersen J, Walls AF, McEuen AR. Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity. Biochem Pharmacol 2003; 66: 2251-62.
77. Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem 2001; 276: 18551-6.
78. Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 2002; 109: 363-71.
79. Guay D, Beaulieu C, Percival MD. Therapeutic utility and medicinal chemistry of cathepsin C inhibitors. Curr Top Med Chem 2010; 10: 708-16.
80. Wolters PJ, Laig-Webster M, Caughey GH. Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways. Am J Respir Cell Mol Biol 2000; 22: 183-90.
81. Mason RW. Emerging functions of placental cathepsins. Placenta 2008; 29: 385-90.
82. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SR, Rosloniec EF, Elliott EA, Rudensky AY. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999; 10: 207-17.
83. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999; 10: 197-206.
84. Driessen C, Bryant RA, Lennon-Dumenil AM, Villadangos JA, Bryant PW, Shi GP, Chapman HA, Ploegh HL. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J Cell Biol 1999; 147: 775-90.
85. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998; 280: 450-3.
86. Tolosa E, Li W, Yasuda Y, Wienhold W, Denzin LK, Lautwein A, Driessen C, Schnorrer P, Weber E, Stevanovic S, Kurek R, Melms A, Brömme D. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest 2003; 112: 517-26.
87. Yasuda Y, Li Z, Greenbaum D, Bogyo M, Weber E, Brömme D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 2004; 279: 36761-70.
88. Brömme D, Li Z, Barnes M, Mehler E. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 1999; 38: 2377-85.
89. Stumptner-Cuvelette P, Benaroch P. Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta 2002; 1542: 1-13.
90. MiheliM, Doberŝek A, Gunar G, Turk D. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. J Biol Chem 2008; 283: 14453-60.
91. Dehrmann FM, Coetzer TH, Pike RN, Dennison C. Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch Biochem Biophys 1995; 324: 93-8.
92. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000; 192: 789-99.
93. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 1995; 92: 3849-53.
94. Novinec M, Grass RN, Stark WJ, Turk V, Baici A, LenariB. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem 2007; 282: 7893-902.
95. Kirschke H, Wiederanders B, Brömme D, Rinne A. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem J 1989; 264: 467-73.
96. Novinec M, LenariB, Baici A. Clusterin is a specific stabilizer and liberator of extracellular cathepsin K. FEBS Lett 2012; 586: 1062-6.
97. Lyo V, Cattaruzza F, Kim TN, Walker AW, Paulick M, Cox D, Cloyd J, Buxbaum J, Ostroff J, Bogyo M, Grady EF, Bunnett NW, Kirkwood KS. Active cathepsins B, L, and S in murine and human pancreatitis. Am J Physiol 2012; 303: G894-903.
98. Han J, Luo T, Gu Y, Li G, Jia W, Luo M. Cathepsin K regulates adipocyte differentiation: possible involvement of type I collagen degradation. Endocr J 2009; 56: 55-63.
99. Yang M, Sun J, Zhang T, Liu J, Zhang J, Shi MA, Darakhshan F, Guerre-Millo M, Clement K, Gelb BD, Dolgnov G, Shi GP. Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol 2008; 28: 2202-8.
100. Yang M, Zhang Y, Pan J, Sun J, Liu J, Libby P, Sukhova GK, Doria A, Katunuma N, Peroni OD, Guerre-Millo M, Kahn BB, Clement K, Shi GP. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 2007; 9: 970-7.
101. Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 2006; 147: 4950-9.
102. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996; 273: 1236-8.
103. Kafienah W, Buttle DJ, Burnett D, Hollander AP. Cleavage of native type I collagen by human neutrophil elastase. Biochem J 1998; 330 Pt 2: 897-902.
104. Vargova V, Pytliak M, Mechirova V. Matrix metalloproteinases. EXS 2012; 103: 1-33.
105. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaiss é JM. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998; 273: 32347-52.
106. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998; 331 Pt 3: 727-32.
107. Boonen S, Rosenberg E, Claessens F, Vanderschueren D, Papapoulos S. Inhibition of cathepsin K for treatment of osteoporosis. Curr Osteoporos Rep 2012; 10: 73-9.
108. Dejica VM, Mort JS, Laverty S, Antoniou J, Zukor DJ, Tanzer M, Poole AR. Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage. Arthritis Res Ther 2012; 14: R113.
109. Hayami T, Zhuo Y, Wesolowski GA, Pickarski M, Duong le T. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 2012; 50: 1250-9.
110. Husmann K, Muff R, Bolander ME, Sarkar G, Born W, Fuchs B. Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog 2008; 47: 66-73.
111. Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol 2009; 175: 1255-69.
112. Lendeckel U, Kahne T, Ten Have S, Bukowska A, Wolke C, Bogerts B, Keilhoff G, Bernstein HG. Cathepsin K generates enkephalin from β-endorphin: a new mechanism with possible relevance for schizophrenia. Neurochem Int 2009; 54: 410-7.
113. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, Nishikawa K, Latz E, Golenbock DT, Aoki K, Ohya K, Imai Y, Morishita Y, Miyazono K, Kato S, Saftig P, Takayanagi H. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 2008; 319: 624-7.
114. Lecaille F, Vandier C, Godat E, Herve-Grepinet V, Brömme D, Lalmanach G. Modulation of hypotensive effects of kinins by cathepsin K. Arch. Biochem Biophys 2007; 459: 129-36.
115. Sage J, Leblanc-Noblesse E, Nizard C, Sasaki T, Schnebert S, Perrier E, Kurfurst R, Brömme D, Lalmanach G, Lecaille F. Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. PLoS One 2012; 7: e43494.
116. Haerteis S, Krappitz M, Bertog M, Krappitz A, Baraznenok V, Henderson I, Lindström E, Murphy JE, Bunnett NW, Korbmacher C. Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S. Pflugers Arch 2012; 464: 353-65.
117. Oliveira M, Assis DM, Paschoalin T, Miranda A, Ribeiro EB, Juliano MA, Brömme D, Christoffolete MA, Barros NM, Carmona AK. Cysteine cathepsin S processes leptin, inactivating its biological activity. J Endocrinol 2012; 214: 217-24.
118. Coppini LP, Barros NM, Oliveira M, Hirata IY, Alves MF, Paschoalin T, Assis DM, Juliano MA, Puzer L, Brömme D, Carmona AK. Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor. Biol Chem 2010; 391: 561-70.
119. Cheng XW, Kuzuya M, Nakamura K, Di Q, Liu Z, Sasaki T, Kanda S, Jin H, Shi GP, Murohara T, Yokota M, Iguchi A. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin α? β 3. Am J Pathol 2006; 168: 685-94.
120. Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, Von Figura K, Paus R, Peters C. Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J 2000; 14: 2075-86.
121. Tobin DJ, Foitzik K, Reinheckel T, Mecklenburg L, Botchkarev VA, Peters C, Paus R. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 2002; 160: 1807-21.
122. Potts W, Bowyer J, Jones H, Tucker D, Freemont AJ, Millest A, Martin C, Vernon W, Neerunjun D, Slynn G, Harper F, Maciewicz R. Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int J Exp Pathol 2004; 85: 85-96.
123. Reinheckel T, Hagemann S, Dollwet-Mack S, Martinez E, Lohmüller T, Zlatkovic G, Tobin DJ, Maas-Szabowski N, Peters C. The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J Cell Sci 2005; 118: 3387-95.
124. Petermann I, Mayer C, Stypmann J, Biniossek ML, Tobin DJ, Engelen MA, Dandekar T, Grune T, Schild L, Peters C, Reinheckel T. Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. FASEB J 2006; 20: 1266-8.
125. Funkelstein L, Beinfeld M, Minokadeh A, Zadina J, Hook V. Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides. Neuropeptides 2010; 44: 457-66.
126. Hagemann S, Gunther T, Dennemarker J, Lohmuller T, Bromme D, Schule R, Peters C, Reinheckel T. The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles. Eur J Cell Biol 2004; 83: 775-80.
127. Funkelstein L, Lu WD, Koch B, Mosier C, Toneff T, Taupenot L, O ' Connor DT, Reinheckel T, Peters C, Hook V. Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters. J Biol Chem 2012; 287: 15232-41.
128. Puzer L, Barros NM, Paschoalin T, Hirata IY, Tanaka AS, Oliveira MC, Brömme D, Carmona AK. Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen. Biol Chem 2008; 389: 195-200.
129. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, Bogyo M, Nepveu A. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 2004; 14: 207-19.
130. Goulet B, Truscott M, Nepveu A. A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L. Biol Chem 2006; 387: 1285-93.
131. Duncan EM, Muratore-Schroeder TL, Cook RG, Garcia BA, Shabanowitz J, Hunt DF, Allis CD. Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 2008; 135: 284-94.
132. Adams-Cioaba MA, Krupa JC, Xu C, Mort JS, Min J. Structural basis for the recognition and cleavage of histone H3 by cathepsin L. Nat Commun 2011; 2: 197.
133. Pandey KC, Dixit R. Structure-function of falcipains: malarial cysteine proteases. J Trop Med 2012; 2012: 345195.
134. Pandey KC, Sijwali PS, Singh A, Na BK, Rosenthal PJ. Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2. J Biol Chem 2004; 279: 3484-91.
135. Pandey KC, Wang SX, Sijwali PS, Lau AL, McKerrow JH, Rosenthal PJ. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci USA 2005; 102: 9138-43.
136. Steverding D, Sexton DW, Wang X, Gehrke SS, Wagner GK, Caffrey CR. Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target. Int J Parasitol 2012; 42: 481-8.
137. Suzuki KM, Hosoya N, Takahashi T, Kosaka T, Hosoya H. Release of a newly-identified cysteine protease, tetrain, from Tetrahymena into culture medium during the cell growth. J Biochem 1997; 121: 642-7.
138. Völkel H, Kurz U, Linder J, Klumpp S, Gnau V, Jung G, Schultz JE. Cathepsin L is an intracellular and extracellular protease in Paramecium tetraurelia. Purification, cloning, sequencing and specific inhibition by its expressed propeptide. Eur J Biochem 1996; 238: 198-206.
139. Sajid M, Robertson SA, Brinen LS, McKerrow JH. Cruzain: the path from target validation to the clinic. Adv Exp Med Biol 2011; 712: 100-15.
140. Stack C, Dalton JP, Robinson MW. The phylogeny, structure and function of trematode cysteine proteases, with particular emphasis on the Fasciola hepatica cathepsin L family. Adv Exp Med Biol 2011; 712: 116-35.
141. Gonzalez-Rabade N, Badillo-Corona JA, Aranda-Barradas JS, Oliver-Salvador Mdel C. Production of plant proteases in vivo and in vitro-a review. Biotechnol Adv 2011; 29: 983-96.
142. Konno K, Hirayama C, Nakamura M, Tateishi K, Tamura Y, Hattori M, Kohno K. Papain protects papaya trees from herbivorous insects: role of cysteine proteases in latex. Plant J 2004; 37: 370-8.
143. Lopez-Garcia B, Hernandez M, Segundo BS. Bromelain, a cysteine protease from pineapple (Ananas comosus) stem, is an inhibitor of fungal plant pathogens. Lett Appl Microbiol 2012; 55: 62-7.
144. Shindo T, Misas-Villamil JC, Horger AC, Song J, van der Hoorn RA. A role in immunity for Arabidopsis cysteine protease RD21, the ortholog of the tomato immune protease C14. PLoS One 2012; 7: e29317.
145. Avci U, Petzold HE, Ismail IO, Beers EP, Haigler CH. Cysteine proteases XCP1 and XCP2 aid micro-autolysis within the intact central vacuole during xylogenesis in Arabidopsis roots. Plant J 2008; 56: 303-15.
146. Otegui MS, Noh YS, Martinez DE, Vila Petroff MG, Staehelin LA, Amasino RM, Guiamet JJ. Senescence-associated vacuoles with intense proteolytic activity develop in leaves of Arabidopsis and soybean. Plant J 2005; 41: 831-44.
147. Brguljan PM, Turk V, Nina C, Brzin J, Krizaj I, Popovic T. Human brain cathepsin H as a neuropeptide and bradykinin metabolizing enzyme. Peptides 2003; 24: 1977-84.
148. Lu WD, Funkelstein L, Toneff T, Reinheckel T, Peters C, Hook V. Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. J Neurochem 2012; 122: 512-22.
149. D ' Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem 2010; 285: 20514-9.
150. Bühling, F. Kouadio M, Chwieralski CE, Kern U, Hohlfeld JM, Klemm N, Friedrichs N, Roth W, Deussing JM, Peters C, Reinheckel T. Gene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in mice. PLoS One 2011; 6: e26247.
151. Dodt J, Reichwein J. Human cathepsin H: deletion of the mini-chain switches substrate specificity from aminopeptidase to endopeptidase. Biol Chem 2003; 384: 1327-32.
152. N ä gler DK, Sulea T, Menard R. Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem Biophys Res Commun 1999; 257: 313-8.
153. Somoza JR, Palmer JT, Ho JD. The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J Mol Biol 2002; 322: 559-68.
154. Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Brömme D,
155. Oorni K, Sneck M, Bromme D, Pentikainen MO, Lindstedt KA, Mayranpaa M, Aitio H, Kovanen PT. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem 2004; 279: 34776-84.
156. Kang JM, Bahk YY, Cho PY, Hong SJ, Kim TS, Sohn WM, Na BK. A family of cathepsin F cysteine proteases of Clonorchis sinensis is the major secreted proteins that are expressed in the intestine of the parasite. Mol Biochem Parasitol 2010; 170: 7-16.
157. Redmond DL, Smith SK, Halliday A, Smith WD, Jackson F, Knox DP, Matthews JB. An immunogenic cathepsin F secreted by the parasitic stages of Teladorsagia circumcincta. Int J Parasitol 2006; 36: 277-86.
158. Sripa J, Laha T, To J, Brindley PJ, Sripa B, Kaewkes S, Dalton JP, Robinson MW. Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B. Cell Microbiol 2010; 12: 781-95.
159. Miyaji T, Murayama S, Kouzuma Y, Kimura N, Kanost MR, Kramer KJ, Yonekura M. Molecular cloning of a multidomain cysteine protease and protease inhibitor precursor gene from the tobacco hornworm (Manduca sexta) and functional expression of the cathepsin F-like cysteine protease domain. Insect Biochem Mol Biol 2010; 40: 835-46.
160. Stoeckle C, Gouttefangeas C, Hammer M, Weber E, Melms A, Tolosa E. Cathepsin W expressed exclusively in CD8 + T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp Hem 2009; 37: 266-75.
161. Velasco G, Ferrando AA, Puente XS, Sanchez LM, Lopez-Otin C. Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. J Biol Chem 1994; 269: 27136-42.
162. Lemaire R, Flipo RM, Migaud H, Fontaine C, Huet G, Dacquembronne E, Lafyatis R. Alternative splicing of the 5 region of cathepsin B pre-messenger RNA in rheumatoid synovial tissue. Arthritis Rheum 1997; 40: 1540-2.
163. Müntener K, Zwicky R, Csucs G, Rohrer J, Baici A. Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death. J Biol Chem 2004; 279: 41012-7.
164. Baici A, Müntener K, Willimann A, Zwicky R. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death. Biol Chem 2006; 387: 1017-21.
165. Caserman S, Kenig S, Sloane BF, Lah TT. Cathepsin L splice variants in human breast cell lines. Biol Chem 2006; 387: 629-34.
166. Tedelind S, Poliakova K, Valeta A, Hunegnaw R, Yemanaberhan EL, Heldin NE, Kurebayashi J, Weber E, Kopitar-Jerala N, Turk B, Bogyo M, Brix K. Nuclear cysteine cathepsin variants in thyroid carcinoma cells. Biol Chem 2010; 391: 923-35.
167. Maubach G, Lim MC, Zhuo L. Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells. Mol Biol Cell 2008; 19: 4238-48.
168. Zeeuwen PL, van Vlijmen-Willems IM, Cheng T, Rodijk-Olthuis D, Hitomi K, Hara-Nishimura I, John S, Smyth N, Reinheckel T, Hendriks WJ, Schalkwijk J. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea. FASEB J 2010; 24: 3744-55.
169. Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, Sweep FC. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest 2010; 40: 591-9.
170. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Brömme D, Weber E, Cataltepe S. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2006; 173: 318-26.
171. Rawlings ND, Tolle DP, Barrett AJ. Evolutionary families of peptidase inhibitors. Biochem J 2004; 378: 705-16.
172. Dubin G. Proteinaceous cysteine protease inhibitors. Cell Mol Life Sci 2005; 62: 653-69.
173. Kordiŝ D, Turk V. Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes. BMC Evol Biol 2009; 9: 266.
174. Langerholc T, Zavaŝnik-Bergant V, Turk B, Turk V, Abrahamson M, Kos J. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J 2005; 272: 1535-45.
175. Martinez M, Cambra I, Gonzalez-Melendi P, Santamaria ME, Diaz I. C1A cysteine-proteases and their inhibitors in plants. Physiol Plant 2012; 145: 85-94.
176. Bocock JP, Edgell CJ, Marr HS, Erickson AH. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur J Biochem 2003; 270: 4008-15.
177. Novinec M, Kordi ŝ D, Turk V, Lenari B. Diversity and evolution of the thyroglobulin type-1 domain superfamily. Mol Biol Evol 2006; 23: 744-755.
178. LenariB, Turk V. Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J Biol Chem 1999; 274: 563-6.
179. Rennenberg A, Lehmann C, Heitmann A, Witt T, Hansen G, Nagarajan K, Deschermeier C, Turk V, Hilgenfeld R, Heussler VT. Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes. PLoS Pathog 2010; 6: e1000825.
180. Kang JM, Ju HL, Yu JR, Sohn WM, Na BK. Cryptostatin, a chagasin-family cysteine protease inhibitor of Cryptosporidium parvum. Parasitology 2012; 139: 1029-37.
181. Ŝari M, Irmer H, Eckert D, Bar AK, Bruchhaus I, Scholze H. The cysteine protease inhibitors EhICP1 and EhICP2 perform different tasks in the regulation of endogenous protease activity in trophozoites of Entamoeba histolytica. Protist 2012; 163: 116-28.
182. Monteiro AC, Abrahamson M, Lima AP, Vannier-Santos MA, Scharfstein J. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J Cell Sci 2001; 114: 3933-42.
183. Renko M, SabotiJ, MiheliM, Brzin J, Kos J, Turk D. Versatile loops in mycocypins inhibit three protease families. J Biol Chem 2010; 285: 308-16.
184. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, Gornstein ER, Brömme D, Chapman HA, Silverman GA. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 1998; 37: 5258-66.
185. Hwang SR, Stoka V, Turk V, Hook VY. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition. Biochemistry 2005; 44: 7757-67.
186. Welss, T, Sun J, Irving JA, Blum R, Smith AI, Whisstock JC, Pike RN, von Mikecz A, Ruzicka T, Bird PI, Abts HF. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 2003; 42: 7381-9.
187. Avila JL, Convit J. Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem J 1975; 152: 57-64.
188. Ishidoh K, Kominami E. Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 1995; 217: 624-31.
189. Vasiljeva O, Dolinar M, Pungerar JR, Turk V, Turk B. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. FEBS Lett 2005; 579: 1285-90.
190. CagliD, Pungerar JR, Pejler G, Turk V, Turk B. Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. J Biol Chem 2007; 282: 33076-85.
191. Li Z, Hou WS, Brömme D. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 2000; 39: 529-36.
192. Li Z, Kienetz M, Cherney MM, James MN, Brömme D. The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol 2008; 383: 78-91.
193. Li Z, Yasuda Y, Li W, Bogyo M, Katz N, Gordon RE, Fields GB, Brömme D. Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 2004; 279: 5470-9.
194. Almeida PC, Nantes IL, Chagas JR, Rizzi CC, Faljoni-Alario A, Carmona E, Juliano L, Nader HB, Tersariol IL. Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem 2001; 276: 944-51.
195. Almeida PC, Nantes IL, Rizzi CC, Judice WA, Chagas JR, Juliano L, Nader HB, Tersariol IL. Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans. J Biol Chem 1999; 274: 30433-8.
196. Costa TF, Reis FC, Lima AP. Substrate inhibition and allosteric regulation by heparan sulfate of Trypanosoma brucei cathepsin L. Biochim Biophys Acta 2012; 1824: 493-501.
197. Williams SC. Potential first-in-class osteoporosis drug speeds through trials. Nat Med 2012; 18: 1158.
198. Barr SC, Warner KL, Kornreic BG, Piscitelli J, Wolfe A, Benet L, McKerrow JH. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob Agents Chemother 2005; 49: 5160-1.
199. Doyle PS, Zhou YM, Engel JC, McKerrow JH. A cysteine protease inhibitor cures Chagas ' disease in an immunodeficient-mouse model of infection. Antimicrob Agents Chemother 2007; 51: 3932-9.
200. Hook V, Hook G, Kindy M. Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce β-amyloid related to Alzheimer ' s disease. Biol Chem 2010; 391: 861-72.
201. Marco M, Coteron JM. Falcipain inhibition as a promising antimalarial target. Curr Top Med Chem 2012; 12: 408-44.